Jessica Cassavaugh, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stiff-Person Syndrome | 1 | 2016 | 28 | 0.600 |
Why?
|
| Neuromuscular Nondepolarizing Agents | 1 | 2016 | 150 | 0.550 |
Why?
|
| Neuromuscular Blockade | 1 | 2016 | 152 | 0.540 |
Why?
|
| Anesthetics, Intravenous | 1 | 2016 | 410 | 0.460 |
Why?
|
| Anesthetics, Inhalation | 1 | 2016 | 557 | 0.410 |
Why?
|
| F-Box Proteins | 1 | 2011 | 204 | 0.380 |
Why?
|
| Cell Hypoxia | 1 | 2011 | 684 | 0.360 |
Why?
|
| Anesthesia, General | 1 | 2016 | 1103 | 0.350 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2011 | 617 | 0.330 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2011 | 1884 | 0.220 |
Why?
|
| Early Ambulation | 1 | 2021 | 46 | 0.210 |
Why?
|
| Cytoskeletal Proteins | 3 | 2012 | 1416 | 0.200 |
Why?
|
| Spinal Cord Ischemia | 1 | 2020 | 82 | 0.190 |
Why?
|
| Paraplegia | 1 | 2020 | 169 | 0.190 |
Why?
|
| Cell Cycle Proteins | 1 | 2011 | 3511 | 0.190 |
Why?
|
| Androstanols | 1 | 2016 | 48 | 0.150 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2020 | 1090 | 0.140 |
Why?
|
| Osteosarcoma | 2 | 2011 | 889 | 0.130 |
Why?
|
| Drainage | 1 | 2020 | 1139 | 0.130 |
Why?
|
| Aortic Diseases | 1 | 2020 | 726 | 0.130 |
Why?
|
| Methyl Ethers | 1 | 2016 | 201 | 0.130 |
Why?
|
| Fentanyl | 1 | 2016 | 402 | 0.120 |
Why?
|
| Gene Expression Regulation | 1 | 2011 | 12435 | 0.110 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2020 | 1318 | 0.100 |
Why?
|
| Up-Regulation | 1 | 2020 | 4356 | 0.100 |
Why?
|
| Propofol | 1 | 2016 | 562 | 0.100 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2011 | 197 | 0.100 |
Why?
|
| Recovery of Function | 1 | 2021 | 2951 | 0.100 |
Why?
|
| RNA | 1 | 2020 | 2748 | 0.100 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2011 | 443 | 0.090 |
Why?
|
| Oxidative Stress | 1 | 2020 | 3179 | 0.090 |
Why?
|
| Patient Discharge | 1 | 2021 | 3030 | 0.080 |
Why?
|
| Critical Illness | 1 | 2021 | 2543 | 0.080 |
Why?
|
| Endovascular Procedures | 1 | 2020 | 1974 | 0.080 |
Why?
|
| Ubiquitination | 1 | 2011 | 1025 | 0.080 |
Why?
|
| Myocardium | 1 | 2020 | 4943 | 0.080 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2011 | 2613 | 0.070 |
Why?
|
| Protein Biosynthesis | 1 | 2012 | 2175 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 4935 | 0.060 |
Why?
|
| Neoplasm Invasiveness | 1 | 2012 | 3704 | 0.060 |
Why?
|
| Protein Kinase C | 1 | 2008 | 1278 | 0.060 |
Why?
|
| Cytoskeleton | 1 | 2008 | 1227 | 0.060 |
Why?
|
| Phosphorylation | 2 | 2011 | 8744 | 0.060 |
Why?
|
| Cell Line, Tumor | 4 | 2012 | 16989 | 0.060 |
Why?
|
| Neoplasm Metastasis | 2 | 2011 | 5101 | 0.060 |
Why?
|
| Diabetes Mellitus | 1 | 2020 | 5455 | 0.060 |
Why?
|
| Actins | 1 | 2008 | 2189 | 0.050 |
Why?
|
| Endoleak | 1 | 2020 | 96 | 0.050 |
Why?
|
| Myocardial Ischemia | 1 | 2011 | 2136 | 0.050 |
Why?
|
| Neovascularization, Pathologic | 1 | 2011 | 2716 | 0.050 |
Why?
|
| Ulcer | 1 | 2020 | 194 | 0.050 |
Why?
|
| Oxygen | 1 | 2011 | 4179 | 0.040 |
Why?
|
| Aneurysm, False | 1 | 2020 | 286 | 0.040 |
Why?
|
| Muscle Strength | 1 | 2021 | 567 | 0.040 |
Why?
|
| Immunoblotting | 1 | 2020 | 1792 | 0.040 |
Why?
|
| Bone Neoplasms | 1 | 2008 | 2594 | 0.040 |
Why?
|
| Aneurysm, Dissecting | 1 | 2020 | 644 | 0.030 |
Why?
|
| Ovarian Neoplasms | 1 | 2011 | 4750 | 0.030 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2020 | 627 | 0.030 |
Why?
|
| Clinical Protocols | 1 | 2020 | 1474 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2008 | 8685 | 0.030 |
Why?
|
| Autophagy | 1 | 2020 | 1347 | 0.030 |
Why?
|
| Female | 5 | 2021 | 377934 | 0.030 |
Why?
|
| Humans | 9 | 2021 | 717280 | 0.030 |
Why?
|
| Activities of Daily Living | 1 | 2021 | 2323 | 0.030 |
Why?
|
| Microscopy, Video | 1 | 2011 | 258 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2012 | 945 | 0.020 |
Why?
|
| Middle Aged | 3 | 2021 | 215054 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 2021 | 3448 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 2011 | 12608 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2012 | 1120 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 3968 | 0.020 |
Why?
|
| Phenotype | 2 | 2012 | 16404 | 0.020 |
Why?
|
| Aged | 3 | 2021 | 162862 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2012 | 5438 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2011 | 4072 | 0.020 |
Why?
|
| Apoptosis | 1 | 2020 | 10119 | 0.020 |
Why?
|
| Transfection | 1 | 2012 | 6142 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2012 | 3993 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2012 | 3615 | 0.010 |
Why?
|
| Neoplasms | 1 | 2011 | 20572 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2020 | 23543 | 0.010 |
Why?
|
| Male | 3 | 2021 | 351399 | 0.010 |
Why?
|
| Gene Expression | 1 | 2011 | 8013 | 0.010 |
Why?
|
| Time Factors | 1 | 2020 | 41094 | 0.010 |
Why?
|
| Wound Healing | 1 | 2008 | 2800 | 0.010 |
Why?
|
| Cell Line | 1 | 2012 | 16693 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2021 | 51277 | 0.010 |
Why?
|
| Cell Movement | 1 | 2008 | 5465 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 58528 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2020 | 62344 | 0.010 |
Why?
|
| Risk Factors | 1 | 2020 | 70863 | 0.010 |
Why?
|
| Mice | 2 | 2011 | 81128 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2020 | 72608 | 0.010 |
Why?
|
| Animals | 2 | 2011 | 170894 | 0.010 |
Why?
|
| Mutation | 1 | 2011 | 29491 | 0.000 |
Why?
|
| Adult | 1 | 2021 | 212470 | 0.000 |
Why?
|